Connect with us

Technology

Zimmer Biomet Showcases Latest Innovations Across Comprehensive Portfolio at AAOS 2024 Annual Meeting

Published

on

— Booth Highlights Include Persona® OsseoTi® Keel Tibia, a Preview of ROSA® Shoulder*, Pending 510(k) Clearance, and the HAMMR™ Automatic Hip Impaction System–

WARSAW, Ind., Feb. 12, 2024 /PRNewswire/ — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is showcasing the latest innovations across its product portfolio at the 2024 annual meeting of the American Academy of Orthopaedic Surgeons (AAOS) this week in San Francisco. During the meeting, the company will display its forthcoming ROSA® Robotics application for shoulder replacement,* which is pending 510(k) clearance, and provide hands-on demonstrations of key growth drivers including Persona® OsseoTi® Keel Tibia for cementless knee replacement, ROSA® Robotics (ROSA Knee and ROSA Hip), Ambulatory Surgery Center (ASC) Solutions, as well as recently launched surgical tools including HAMMR™ Automatic Hip Impaction System, and the ViVi® Surgical Helmet System.

“Every year, the annual AAOS meeting gives us an opportunity to not only demonstrate the breadth and diversity of our portfolio, but also shine a spotlight on the bold and meaningful innovations that transform clinical care, improve the surgical experience, and give us a differentiated competitive advantage,” said Mark Bezjak, President of the Americas at Zimmer Biomet. “From our cementless construct, Persona OsseoTi Keel Tibia, to our ROSA Robotics platform powered by ZBEdge™ Dynamic Intelligence™, we’re excited to share our customer-centric solutions with surgeons from around the world.”

Here are the highlights at the Zimmer Biomet booth (#1127):  

Best-in-Class ImplantsPersona® OsseoTi® Keel Tibia for cementless knee replacement: Launched in 2023, this cementless construct offers stable*1 initial and biological fixation with OsseoTi® porous keel design, versatility to switch between cemented and cementless approach intra-operatively, and an anatomic design for proper rotation and optimal bone coverage.Surgical ToolsHAMMR™ Automatic Hip Impaction System for bone preparation and implant placement during hip replacement surgery: Designed to deliver consistent and controlled energy2 to address surgeon strain, fatigue and repetitive motion associated with a traditional mallet.ViVi® Surgical Helmet System that keeps clinicians cool and comfortable, while providing clear visibility for precise surgical procedures. Illuminated by a powerful 100,000 Lux LED light, ViVi is the quietest3 and most lightweight4,5 surgical helmet available†.Robotics and Data Intelligence ROSA® Robotics: Comprehensive, multi-application platform for knee and hip procedures. Designed for Zimmer Biomet’s leading implants and data technologies, ROSA Robotics redefines robotics by providing real-time insights with the goal to optimize outcomes and revolutionize the standard of care.ZBEdge™ Dynamic Intelligence™: Elevates and unlocks the full potential of Zimmer Biomet’s cutting-edge digital, robotic and implant solutions. ZBEdge technologies collect objective data before, during and after surgery, and then deliver actionable insights to help surgeons make the most informed decision possible.

In addition, the company will provide updates on its ASC strategy, partnerships and comprehensive portfolio. For more information about Zimmer Biomet events at AAOS 2024, visit http://www.zimmerbiomet.com/academy2024

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

Cautionary Statement Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of forward-looking terms such as “may,” “will,” “expects,” “believes,” “aims,” “anticipates,” “plans,” “looking forward to,” “estimates,” “projects,” “assumes,” “guides,” “targets,” “forecasts,” “continue,” “seeks” or the negatives of such terms or other variations on such terms or comparable terminology. Forward-looking statements include, but are not limited to, statements concerning the Company’s expectations, plans, intentions, strategies, prospects, business plans, product and service offerings, new product launches, potential clinical successes, and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks and uncertainties that could cause actual outcomes and results to differ materially. Some of these risks and uncertainties can be found in Zimmer Biomet’s Annual Report on Form 10-K for the year ended December 31, 2022 and subsequent periodic reports filed with the Securities and Exchange Commission (SEC). Copies of these filings are available online at www.sec.govwww.zimmerbiomet.com or on request from the Company. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in the Company’s filings with the SEC. Such forward-looking statements speak only as of the date made, and the Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this press release are cautioned not to place undue reliance on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this press release.

References

* ROSA Shoulder is currently pending 510(k) clearance and is not commercially available.
† Versus market-share leaders
* Laboratory testing may not be indicative of clinical results.
1 Mueller J.K., et al. Persona OsseoTi Keel Tibia Provides Stable Initial Fixation 4027.2-GLBL-en. November 2022. Laboratory testing may not be indicative of clinical results.
2 Data on File at Zimmer Biomet. Zimmer HAMMR Verification Test Report. DOC0179677. Pages 47-49. January 19, 2024.
3 MD 7.6.3 – TR_ViVi Noise_Competitor Analysis_Rev.01. Page 2. August 24, 2023. Data on file at Zimmer Biomet.
4 THI Airflow-Weight-Light-Noise Summary Report ENG. Page 8. May 31, 2023. Data on file at Zimmer Biomet.
5 THI – Weight – Noise – FOV file. Page 3. September 26, 2023. Data on file at Zimmer Biomet.

Media

Investors

Heather Zoumas-Lubeski

Zach Weiner

445-248-0577

908-591-6955

heather.zoumaslubeski@zimmerbiomet.com

zach.weiner@zimmerbiomet.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-showcases-latest-innovations-across-comprehensive-portfolio-at-aaos-2024-annual-meeting-302059155.html

SOURCE Zimmer Biomet Holdings, Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Verndale Welcomes Max Fresen as Chief Experience Officer

Published

on

By

New CXO Brings Over Two Decades of Experience in Advertising and Marketing to Lead the Agency’s Experience Design Team

BOSTON, March 5, 2024 /PRNewswire/ — Verndale, a digital experience agency headquartered in Boston, MA, announced the appointment of Max Fresen as their Chief Experience Officer (CXO). Max joins Verndale from BRANDtho, where he successfully led as CXO, bringing with him over two decades of invaluable experience in the advertising and marketing industry.

Following 2023 investments in the strategy team, Verndale welcomes a new CXO to steward innovation in experience design.

As CXO at Verndale, Max will play a pivotal role in charting the agency’s future. He’ll lead the experience design team and drive initiatives that align with the organization’s strategic goals.

Chris Pisapia, CEO of Verndale, shares, “As we steer Verndale through our transformative growth as a company, our focus on delivering business value remains. Balancing technical expertise with strategic creativity is key. Following our investments in the agency’s strategy team in 2023, we’re thrilled to announce Max Fresen’s hire to steward innovation in experience design. This move expands our creative services and reflects our commitment to redefining digital experiences and propelling clients’ initiatives forward.”

Max’s recruitment reinforces the agency’s commitment to excellence and innovation. In his role as the head of experience design, Max will be responsible for delivering engaging and impactful experiences across all channels and platforms, contributing to Verndale’s evolution as a strategic partner to its clients.

“I’m thrilled to join Verndale at this pivotal moment in the evolution of communication arts. In an era where generative technologies have made the once impossible commonplace, capturing customers’ attention and building a brand has become more challenging than ever,” comments Max. “Navigating the intersection of art and science is now essential for a company’s success. With Verndale’s decades of experience crafting tech-enabled experiences at an enterprise scale, we’re uniquely positioned to be the ideal partner for this transformative journey. I’m excited to contribute to Verndale’s mission and drive impactful outcomes for our clients and their customers.”

Max’s extensive experience and leadership at previous agencies prime him to lead and grow the Experience Design team and drive outcomes for our clients. His passion for pushing the boundaries of technology and psychology and his commitment to making the world a better place through design and innovation make him a valuable addition to the Verndale team. 

About Verndale

Verndale is a digital agency that designs, develops, and delivers high-performing websites and ecommerce experiences. The agency guides clients in creating more human experiences in a digital world and is committed to pushing boundaries, achieving growth objectives, and optimizing digital experiences for its clients and their customers. Verndale offers digital strategy, experience design, digital marketing, customer relationship management (CRM), and sales quoting solutions. The agency leverages best-in-class technologies to deliver clients custom solutions that stand above the rest.

As a recognized Optimizely Premium partner, Verndale has earned seven MVP awards, holds 60 certifications, and boasts 30 global accreditations. In 2023 and 2021, the agency was honored with the Optimizely Partner of the Year award. Verndale is also North America’s leading Sitecore Enterprise Solution provider and Platinum partner. With nine MVPs and 25 certified developers, Verndale’s specializations include Experience Platform, XM Cloud, OrderCloud, CDP & Personalization, and Content Hub. 

For more information about Verndale’s innovative solutions and industry expertise, visit verndale.com. Get in touch with us at hello@verndale.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/verndale-welcomes-max-fresen-as-chief-experience-officer-302078945.html

SOURCE Verndale Corporation

Continue Reading

Technology

EMA Research Webinar to Explore How Enterprises Can Be More Successful with Their Network Automation Initiatives

Published

on

By

According to new research from EMA, only 18% of network automation initiatives are a complete success

LAFAYETTE, Colo., March 5, 2024 /PRNewswire-PRWeb/ — Enterprise Management Associates (EMA™), a leading IT and data management analyst research and consulting firm, today announced it will host a research webinar titled “Enterprise Network Automation: Emerging from the Dark Ages and Reaching Toward NetDevOps,” based on recent research by Shamus McGillicuddy, EMA’s vice president of research covering network management. The research explores the challenges and opportunities of network automation for enterprise IT organizations.

Network automation continues to be a science project for too many companies. With this research, I tried to identify a path forward for IT decision-makers.

According to EMA’s new research, only 18% of network automation initiatives are a complete success. This indicates that network automation remains a significant challenge for many organizations. The webinar will provide insights and guidance to help organizations improve the success of their network automation initiatives.

During this webinar, McGillicuddy will share highlights from this new research, including:

Why nine out of ten IT organizations rely on a mix of vendor solutions and do-it-yourself network automation toolsHow network teams establish an authoritative network source of truth to drive effective network automationHow network teams validate network changes and monitor network complianceWhat pitfalls organizations should look out for on their network automation journey

“The IT industry has been attacking the problem of network automation for decades, and we still cannot get it right,” McGillicuddy said. “There are countless reasons for this ongoing struggle, including complexity, data quality and authority problems, and budget issues. As a result, network automation continues to be a science project for too many companies. With this research, I tried to identify a path forward for IT decision-makers.”

This independent research is sponsored by EfficientIP, IPFabric, NetBox Labs, NetBrain.

The webinar will take place on Tuesday, March 12 at 2:00 p.m. Eastern. Registration is available at: https://info.enterprisemanagement.com/enterprise-network-automation-webinar-pr

About EMA
Founded in 1996, EMA is a leading IT analyst research firm that provides deep insight across the full spectrum of IT and data management technologies. EMA analysts leverage a unique combination of practical experience, insight into industry best practices, and in-depth knowledge of current and planned vendor solutions to help their clients achieve their goals. Learn more about EMA research, analysis, and consulting services for enterprise line of business users, IT professionals, and IT vendors at https://www.enterprisemanagement.com

Media Contact

Raleigh Gould, Enterprise Management Associates, 303-543-9500, rgould@emausa.comhttps://www.enterprisemanagement.com 

Twitter

View original content to download multimedia:https://www.prweb.com/releases/ema-research-webinar-to-explore-how-enterprises-can-be-more-successful-with-their-network-automation-initiatives-302079653.html

SOURCE Enterprise Management Associates

Continue Reading

Technology

Pioneer in Cyber Insurance in Brazil Receives $1.5 Million Funding

Published

on

By

Bluecyber, which offers digital protection insurance to SMEs and families, will expand its operations in Latin America

SÃO PAULO, March 5, 2024 /PRNewswire/ — Bluecyber.insure, a pioneering insurtech in cyber insurance in Brazil, has received a $1.5 million investment from VCs Invisto.com.vc and Bossa Invest, as well as strategic investors from the insurance market. “This investment reflects the investors’ confidence in Bluecyber’s mission to simplify and expand insurance coverage for digital life protection of SMEs and families throughout Latin America, an underserved market with an estimated gross written premium (GWP) of USD 17.3 billion,” says Eduardo Rocha, CEO of Bluecyber.

The investment has already enabled the acquisition of Ismac.io, which developed an innovative Managed Detection and Response (MDR) platform. “This solution allows Bluecyber to continuously monitor its insured portfolio, detecting and responding to security incidents swiftly and efficiently, minimizing the impact of attacks, and delivering more value to the insured, as well as reducing the frequency and severity of claims,” explains Daniel Arruda, Ismac’s founder, who will take over the management of risk and compliance at Bluecyber.

In addition to financial compensation for claims such as data breaches, fines related to local General Data Protection Regulations (GDPR), legal fees, and digital identity theft, the monthly cyber protection insurance subscription offers a help desk for everyday technological issues, antivirus, vulnerability monitoring, risk management, and incident response.

“We are confident that this new phase will be a watershed in the cyber insurance industry, offering innovative and comprehensive solutions,” says Bluecyber’s co-founder Claudio Macedo.

About Bluecyber

Founded in 2021, Bluecyber is a Managing General Agent (MGA) specializing in cyber insurance. It develops products tailored to the needs centered around customer-centricity, structures underwriting capacity with reinsurers and insurers, and cultivates innovative distribution channels. The B2B product sales are conducted entirely digitally through non-traditional channels, including internet providers, software and hardware manufacturers, as well as insurance brokers. Bluecyber aims to conclude 2024 with 10,000 subscribers, striving to simplify cyber protection. Seguros Sura, one of the largest insurance groups in Latin America, serves over 20 million insureds across seven countries and is the issuer of the policies, complying with all regulatory requirements.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/pioneer-in-cyber-insurance-in-brazil-receives-1-5-million-funding-302078880.html

SOURCE Bluecyber

Continue Reading

Trending